| Literature DB >> 19833454 |
M Fekih1, A Jnifene, K Fathallah, L Ben Regaya, A Memmi, S Bouguizene, A Chaieb, M Bibi, H Khairi.
Abstract
OBJECTIVES: To assess the benefit of sublingual misoprostol in addition to standard oxytocin in the prevention of post-partum hemorrhage at caesarean section. PATIENTS AND METHODS: This was a prospective randomized controlled clinical trial conducted from March to June 2007 at our department of obstetrics-Sousse-Tunisia, including 250 single low risk pregnant women undergoing caesarean section at gestational age>32 weeks gestation. Patients were randomly assigned to receive at cord clamping either sublingual 200microg misoprostol (Cytotec) with 20UI intravenous oxytocin (Oxytocin): bolus 10UI and infusion 10UI in 500ml Ringer Lactate): Group I, or only oxytocin at the same dose: Group II. The main outcome was total blood loss assessed by decrease in perioperative hematocrit. Secondary outcomes included measured collected blood loss, drop in hemoglobin level, additional oxytocin, side-effects and postoperative complications.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19833454 DOI: 10.1016/j.jgyn.2009.09.006
Source DB: PubMed Journal: J Gynecol Obstet Biol Reprod (Paris) ISSN: 0150-9918